EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment

Todd J Schwedt, Ashley Martin iD, Steven Kymes, Brian Talon, Xin Ying Lee, Roger Cady, Divya Asher, Meghana Karnik-Henry, Emily Mulvihill, Dawn Bates, Kathleen Beusterien

Headache: The Journal of Head and Face Pain · 2023

DOI: 10.1111/head.14476 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, 2023. Written by Todd J Schwedt and 10 co-authors. Institution: Mayo Clinic, Phoenix, Arizona, USA. Major MEDLINE topics: Patient Preference, Migraine Disorders. Cited 17 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Lundbeck LLC.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To assess preferences among adults with migraine for differentiating attributes of injected or infused preventive treatment options and evaluate their importance in determining a treatment choice.

Background

Adults with migraine and health‐care providers consider many factors when making treatment decisions. Injected or infused preventive migraine treatment options differ in several attributes, including mode of administration and dosing frequency, which may be preferentially selected or avoided by patients. Understanding a patient's preference is important for clinicians as they advise on various treatment options.

Methods

A total of 604 US adults diagnosed with migraine participated in an online survey that captured information on demographics, migraine history, and treatment preferences. A discrete choice experiment (DCE) was used to evaluate participants’ preferences for specific attributes of injected/infused preventive migraine therapies. The DCE data were utilized to estimate attribute importance (expressed as a percentage) and identify subgroups that had different distributions of preferences.

Results

In the overall migraine population, mode of administration (28.8%), durability of effectiveness (27.0%), and speed of onset (25.5%) had the highest relative importance, whereas administration setting (9.9%) and dosing frequency (8.8%) had the lowest. Four distinct subgroups were identified: Group 1 ( n = 128) preferred self‐injection administration and durability of effectiveness; Group 2 ( n = 189) expressed aversion to cranial injections; Group 3 ( n = 158) prioritized rapid speed of onset; and Group 4 ( n = 129) favored health‐care provider administration and durability of effectiveness.

Conclusions

Speed of onset, durability of effectiveness, and mode of administration are key moderators of treatment preference among US adults with migraine. Certain segments of the migraine population prioritize specific treatment attributes over others, with intravenous infusion not considered a barrier in three of four identified segments. Clinicians can best help their patients find the right medication if they understand which medication attributes are most and least important to them.

Subjects

MeSH terms (MEDLINE)

Patient PreferenceMigraine DisordersAdultHumansChoice BehaviorDecision MakingInjections

Author keywords

discrete choice experimentmigrainepatient preferencepreventive treatment

Authors and institutions

  • Mayo Clinic, Phoenix, Arizona, USA.
  • Cerner Enviza, Kansas City, Missouri, USA.
  • Lundbeck LLC, Deerfield, Illinois, USA.
  • H. Lundbeck A/S, Copenhagen, Denmark.
  • RK Consults, Ozark, Missouri, USA.
  • Missouri State University, Springfield, Missouri, USA.

ORCID profiles: Ashley Martin

Funding

  • Lundbeck LLC

Cite

APA

Schwedt, T. J., Martin, A., Kymes, S., Talon, B., Lee, X. Y., Cady, R., Asher, D., Karnik-Henry, M., Mulvihill, E., Bates, D., & Beusterien, K. (2023). Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14476

Vancouver

Schwedt TJ, Martin A, Kymes S, Talon B, Lee XY, Cady R, et al. Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment. Headache: The Journal of Head and Face Pain. 2023. doi:10.1111/head.14476

BibTeX
@article{Schwedt2023,
  author = {Schwedt, Todd J and Martin, Ashley and Kymes, Steven and Talon, Brian and Lee, Xin Ying and Cady, Roger and Asher, Divya and Karnik-Henry, Meghana and Mulvihill, Emily and Bates, Dawn and Beusterien, Kathleen},
  title = {Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2023},
  doi = {10.1111/head.14476}
}
Start for free →